As of 2025-07-11, the Gross Margin of Nurix Therapeutics Inc (NRIX) is 7775.2%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-11-30 | 7775.2% |
2023-11-30 | - |
2022-11-30 | - |
2021-11-30 | - |
2020-11-30 | - |
2019-11-30 | - |
2018-11-30 | - |
- | |
- | |
- |